Latest Market Share News

Regal Partners Global Investments (ASX:RG1) reversed last year's losses with a $141.6 million net profit, driven by strong returns in semiconductors, gold, and European banks. The company declared a fully franked final dividend of 5.0 cents per share and continued its on-market share buy-back program.

Cogstate Ltd (ASX:CGS) posted a 15.9% rise in profit before tax to US$16.1 million for FY26, driven by a 116% surge in clinical trial sales contracts to $89 million and a 15% revenue increase. The company doubled its final dividend to A$0.04 per share, supported by a strong $118.5 million contracted revenue backlog.

HUB24 Limited (ASX:HUB) delivered a standout FY26 with 23% revenue growth, 30% EBITDA increase, and record platform net inflows of $18.9 billion, while boosting dividends by 39%.

Judo Bank posted a 34% rise in profit before tax to $168 million for FY26, driven by robust loan book growth and operating leverage, despite increased impairment expenses.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

Challenger Limited delivered a solid FY26 with normalised net profit after tax rising 3% to $468 million, supported by record annuity sales and strategic partnerships. The company also declared a 7% higher fully franked dividend and announced an upsized $450 million share buy-back.

Reliance Worldwide Corporation has agreed to an exclusivity period with Brookfield Capital Partners over a A$4.75 per share acquisition proposal, valuing the company at around A$4.1 billion. The deal includes a 30-day go-shop provision allowing alternative bids.

Regal Asian Investments (ASX:RG8) posted a stellar FY26 with a net profit after tax of $124.8 million, driven by a 52.6% net portfolio return and a 10 cent fully franked final dividend, reflecting strong exposure to Asian semiconductors amid the AI boom.

JB Hi-Fi delivered a solid FY26 with record revenue and profit growth, declaring a 22.5% higher dividend and advancing its net-zero emissions goal.

GWA Group posted modest revenue and earnings growth in FY26, driven by volume gains across Australia, New Zealand, and the UK, while raising dividends and advancing strategic priorities despite challenging market conditions.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

IMDEX Limited (ASX:IMD) delivered a standout FY26 with 21% revenue growth to $520 million and a 44% jump in net profit to $79 million, driven by organic growth and five key acquisitions. The company raised its dividend and expanded its digital earth science footprint, positioning for further gains.